| 292 |
Case Study/Series
|
Five Case Studies from the TOPICS Program- Treatment of Various Wound Types in a Clinical Setting with a Novel BCT Gel formulation First Author: Kimberly Miner Authors: Kimberly Miner ND, CNS, CWCN, FAPWCA Roberto A. Penne-Casanova MD, MPHT, CWS Douglas C. Schuckmann DPM, FACFAS, FAPWCA Mark W. Trumbore PhD Successful management of open wounds requires an effective occlusive barrier, adequate blood flow to the wound, effective debridement of necrotic tissue, infection control and pressure relief. Optimized BCT (balsam peru, castor oil, trypsin) formulations can improve wound visualization, provide an effective protective barrier and minimize trauma to the wound upon application, aiding healing while decreasing the workload for wound care specialists and caregivers. An uncontrolled, open label, multi-center program has been initiated to evaluate the efficacy of a novel BCT Gel wound treatment in a "real life" clinical setting. The program is designed to provide a framework for evaluating the efficacy of BCT Gel in treating a variety of wounds in both the clinic and home care settings. This poster will report on 5 selected case studies from patients with varying wound types and severity that were treated in this on-going study. Study Design: Uncontrolled, open label, multi-center clinical evaluation program. After determining that the patient is a candidate for BCT treatment, patients are treated with BCT Gel applied according to the approved labeling instructions, twice daily or as directed for a maximum of 60 days or until healing has occurred. The treatment protocol allows additional supportive measures per standard of care guidelines. No other pharmacological wound treatments will be used. Weekly assessments with photographs and size measurements as well as qualitative assessments will be recorded. Endpoints include percentage and rate of healing, ease of use and overall clinical satisfaction. |
|